Page last updated: 2024-10-29

ifosfamide and Cystadenocarcinoma, Serous

ifosfamide has been researched along with Cystadenocarcinoma, Serous in 5 studies

Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)

Research Excerpts

ExcerptRelevanceReference
" The aim of this retrospective study was to evaluate the activity and toxicity of bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer."1.40Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases. ( Li, Y; Shang, YM; Yang, Y; Zheng, H, 2014)
"Patients with stage I ovarian cancer show a high incidence of recurrent disease ranging from 30% to 50%, which may be associated with a shortened survival."1.31The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma. ( Aydiner, A; Bengisu, E; Berkman, S; Eralp, Y; Saip, P; Saliho, Y; Salihoğlu, Y; Taş, F; Topuz, E, 2001)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sueoka, K1
Umayahara, K1
Abe, A1
Usami, T1
Yamamoto, A1
Nomura, H1
Matoda, M1
Okamoto, S1
Omatsu, K1
Kondo, E1
Kato, K1
Takeshima, N1
Li, Y1
Yang, Y1
Shang, YM1
Zheng, H1
Zylberberg, B1
Dormont, D1
Madelenat, P1
Daraï, E1
Fruscio, R1
Colombo, N1
Lissoni, AA1
Garbi, A1
Fossati, R1
Ieda', N1
Torri, V1
Mangioni, C1
Topuz, E1
Eralp, Y1
Saip, P1
Aydiner, A1
Taş, F1
Saliho, Y1
Salihoğlu, Y1
Berkman, S1
Bengisu, E1

Trials

2 trials available for ifosfamide and Cystadenocarcinoma, Serous

ArticleYear
First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer.
    European journal of gynaecological oncology, 2004, Volume: 25, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Ca

2004
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
    British journal of cancer, 2008, Feb-26, Volume: 98, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemother

2008

Other Studies

3 other studies available for ifosfamide and Cystadenocarcinoma, Serous

ArticleYear
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin

2015
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases.
    Indian journal of cancer, 2014, Volume: 51 Suppl 3

    Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined C

2014
The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.
    European journal of gynaecological oncology, 2001, Volume: 22, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

2001